RetractedArticleInternational journal of general medicine2021

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma.

Changming Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.